Literature DB >> 24718539

[Tuberculosis and diabetes co-morbidity: an unresolved problem].

César Ugarte-Gil1, David A J Moore1.   

Abstract

Co-morbidity between tuberculosis and diabetes has been described since the early 20th century. In developed countries, where there has been a decrease of infectious diseases with an increase of non-communicable diseases, as well as those countries who still have a high prevalence of infectious diseases but an increase of non-communicable diseases, it is observed that the prevalence of co-morbidity between tuberculosis and diabetes is increasing, making clinical management and control at the public health level a new challenge for health systems. This review aims to show the current available evidence that can inform research lines being developed to understand the problem. In countries like Peru, where there is an epidemiological transition, further research could allow us to understand and describe in a better way the characteristics and impact of this co-morbidity.

Entities:  

Mesh:

Year:  2014        PMID: 24718539

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  5 in total

1.  [Type 2 diabetes mellitus in peru: a systematic review of prevalence and incidence in the general population].

Authors:  Rodrigo M Carrillo-Larco; Antonio Bernabé-Ortiz
Journal:  Rev Peru Med Exp Salud Publica       Date:  2019-05-13

2.  Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis.

Authors:  Qianqian Liu; Wenzhang Li; Miao Xue; Yunfeng Chen; Xinmiao Du; Chengdi Wang; Lina Han; Yin Tang; Yulin Feng; Chuanmin Tao; Jian-Qing He
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

Review 3.  [Co-management of tuberculosis and diabetes: an integrative reviewManejo integrado de la tuberculosis y la diabetes: revisión integrativa].

Authors:  Cíntia Vieira Nascimento; Sônia Maria Soares
Journal:  Rev Panam Salud Publica       Date:  2019-02-06

4.  Severe pulmonary radiological manifestations are associated with a distinct biochemical profile in blood of tuberculosis patients with dysglycemia.

Authors:  Nadia Nilda Barreda; Maria B Arriaga; Juan Gonzalo Aliaga; Kattya Lopez; Oswaldo Martin Sanabria; Thomas A Carmo; José F Fróes Neto; Leonid Lecca; Bruno B Andrade; Roger I Calderon
Journal:  BMC Infect Dis       Date:  2020-02-14       Impact factor: 3.090

5.  [Prevalence of comorbidity tuberculosis and diabetes mellitus in Paraguay, 2016 and 2017Prevalência de comorbidade tuberculose-diabetes mellitus no Paraguai, 2016 e 2017].

Authors:  Cynthia Céspedes; Lucelly López; Sarita Aguirre; Alberto Mendoza-Ticona
Journal:  Rev Panam Salud Publica       Date:  2019-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.